TARGETID	SampleID	SamplesIDshort	Gender	Race	Ethnicity	Age.at.Diagnosis.in.Days	First.Event	Event.Free.Survival.Time.in.Days	Vital.Status	Overall.Survival.Time.in.Days	Year.of.Diagnosis	Year.of.Last.Follow.Up	INSS.Stage	MYCN.status	Ploidy	Histology	Grade	Diagnostic.Category	COG.Risk.Group	TMM_Case	TMM
PAIFXV	TARGET.30.PAIFXV.01A	TARGET.30.PAIFXV	Female	White	Unknown	2004	Event	627	Dead	1111	1995	1998	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Unknown	Unknown	High Risk	TMM	ALT
PAIPGU	TARGET.30.PAIPGU.01A	TARGET.30.PAIPGU	Female	White	Unknown	898	Death	435	Dead	435	1998	1999	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unknown	Unknown	Unknown	High Risk	TMM	Telomerase
PAISNS	TARGET.30.PAISNS.01A	TARGET.30.PAISNS	Male	White	Unknown	1070	Event	410	Dead	421	1998	1999	Stage 4	Not Amplified	Diploid (DI=1)	Unknown	Unknown	Unknown	High Risk	TMM	ALT
PAIVHE	TARGET.30.PAIVHE.01A	TARGET.30.PAIVHE	Male	White	Not Hispanic or Latino	1123	Event	669	Dead	1602	1999	2003	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAKYZS	TARGET.30.PAKYZS.01A	TARGET.30.PAKYZS	Male	White	Not Hispanic or Latino	659	Progression	238	Alive	3587	2001	2011	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unknown	Unknown	Unknown	High Risk	TMM	Telomerase
PAKZRH	TARGET.30.PAKZRH.01A	TARGET.30.PAKZRH	Male	White	Hispanic or Latino	21	Censored	3341	Alive	3341	2001	2010	Stage 4s	Not Amplified	Diploid (DI=1)	Favorable	Undifferentiated or Poorly Differentiated	Unknown	Intermediate Risk	NO_TMM	NO_TMM
PALBFW	TARGET.30.PALBFW.01A	TARGET.30.PALBFW	Male	White	Not Hispanic or Latino	804	Relapse	611	Dead	1073	2001	2004	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PALCBW	TARGET.30.PALCBW.01A	TARGET.30.PALCBW	Female	White	Not Hispanic or Latino	679	Censored	4565	Alive	4565	2001	2014	Stage 4	Not Amplified	Diploid (DI=1)	Favorable	Differentiating	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PALETP	TARGET.30.PALETP.01A	TARGET.30.PALETP	Female	White	Not Hispanic or Latino	1466	Death	251	Dead	251	2001	2002	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PALEVG	TARGET.30.PALEVG.01A	TARGET.30.PALEVG	Male	White	Not Hispanic or Latino	666	Censored	4948	Alive	4948	2001	2015	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PALIIN	TARGET.30.PALIIN.01A	TARGET.30.PALIIN	Male	White	Not Hispanic or Latino	1279	Relapse	684	Dead	1395	2002	2005	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PALKUC	TARGET.30.PALKUC.01A	TARGET.30.PALKUC	Female	Black or African American	Not Hispanic or Latino	823	Censored	4399	Alive	4399	2002	2014	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PALUYS	TARGET.30.PALUYS.01A	TARGET.30.PALUYS	Female	White	Not Hispanic or Latino	1214	Relapse	693	Dead	1284	2002	2006	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PALVKK	TARGET.30.PALVKK.01A	TARGET.30.PALVKK	Female	White	Not Hispanic or Latino	1810	Event	217	Dead	1033	2002	2005	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	ALT
PALWVJ	TARGET.30.PALWVJ.01A	TARGET.30.PALWVJ	Male	Black or African American	Not Hispanic or Latino	1544	Relapse	417	Dead	803	2002	2004	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PALXTB	TARGET.30.PALXTB.01A	TARGET.30.PALXTB	Male	White	Not Hispanic or Latino	635	Censored	4257	Alive	4257	2002	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PALZZV	TARGET.30.PALZZV.01A	TARGET.30.PALZZV	Female	Black or African American	Not Hispanic or Latino	699	Event	1494	Alive	1934	2002	2008	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAMEZH	TARGET.30.PAMEZH.01A	TARGET.30.PAMEZH	Female	Black or African American	Not Hispanic or Latino	746	Death	330	Dead	330	2003	2004	Stage 4	Amplified	Hyperdiploid (DI>1)	Unknown	Unknown	Unknown	High Risk	TMM	Telomerase
PAMMXF	TARGET.30.PAMMXF.01A	TARGET.30.PAMMXF	Male	Unknown	Not Hispanic or Latino	1661	Relapse	140	Dead	197	2003	2004	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAMNLH	TARGET.30.PAMNLH.01A	TARGET.30.PAMNLH	Female	White	Not Hispanic or Latino	1531	Relapse	361	Dead	837	2003	2005	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PAMYCE	TARGET.30.PAMYCE.01A	TARGET.30.PAMYCE	Female	White	Not Hispanic or Latino	1059	Relapse	392	Dead	995	2004	2006	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAMZGT	TARGET.30.PAMZGT.01A	TARGET.30.PAMZGT	Male	White	Not Hispanic or Latino	602	Relapse	603	Alive	3823	2004	2014	Stage 4	Amplified	Diploid (DI=1)	Unknown	Unknown	Neuroblastoma	High Risk	TMM	Telomerase
PAMZMG	TARGET.30.PAMZMG.01A	TARGET.30.PAMZMG	Female	White	Not Hispanic or Latino	614	Relapse	533	Dead	763	2004	2006	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PANBJH	TARGET.30.PANBJH.01A	TARGET.30.PANBJH	Female	Black or African American	Not Hispanic or Latino	1030	Progression	168	Dead	920	2004	2006	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PANBMJ	TARGET.30.PANBMJ.01A	TARGET.30.PANBMJ	Male	White	Not Hispanic or Latino	993	Relapse	577	Dead	3776	2004	2014	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PANGXK	TARGET.30.PANGXK.01A	TARGET.30.PANGXK	Male	White	Not Hispanic or Latino	1266	Event	1855	Alive	3792	2004	2015	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	NO_TMM	NO_TMM
PANJLH	TARGET.30.PANJLH.01A	TARGET.30.PANJLH	Male	White	Not Hispanic or Latino	1010	Death	500	Dead	500	2004	2006	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PANKFE	TARGET.30.PANKFE.01A	TARGET.30.PANKFE	Female	White	Not Hispanic or Latino	1280	Censored	402	Alive	402	2004	2006	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PANLET	TARGET.30.PANLET.01A	TARGET.30.PANLET	Female	Unknown	Unknown	1973	Relapse	830	Dead	1212	2005	2008	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Unknown	Ganglioneuroblastoma, nodular	High Risk	TMM	ALT
PANNMS	TARGET.30.PANNMS.01A	TARGET.30.PANNMS	Female	White	Not Hispanic or Latino	1080	Censored	3509	Alive	3509	2005	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Unknown	Neuroblastoma	High Risk	TMM	Telomerase
PANRRW	TARGET.30.PANRRW.01A	TARGET.30.PANRRW	Male	White	Not Hispanic or Latino	1730	Relapse	408	Alive	2178	2005	2011	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Unknown	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PANRVJ	TARGET.30.PANRVJ.01A	TARGET.30.PANRVJ	Male	White	Not Hispanic or Latino	4781	Censored	3722	Alive	3722	2005	2015	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Differentiating	Neuroblastoma	High Risk	TMM	ALT
PANSBN	TARGET.30.PANSBN.01A	TARGET.30.PANSBN	Male	White	Not Hispanic or Latino	2329	Relapse	505	Dead	836	2005	2007	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Differentiating	Ganglioneuroblastoma, nodular	High Risk	NO_TMM	NO_TMM
PANWRR	TARGET.30.PANWRR.01A	TARGET.30.PANWRR	Male	White	Not Hispanic or Latino	2937	Progression	267	Dead	345	2005	2006	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Differentiating	Neuroblastoma	High Risk	TMM	Telomerase
PANXJL	TARGET.30.PANXJL.01A	TARGET.30.PANXJL	Male	Unknown	Unknown	5734	Censored	431	Alive	431	2005	2006	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	ALT
PANYGR	TARGET.30.PANYGR.01A	TARGET.30.PANYGR	Male	Unknown	Not Hispanic or Latino	993	Progression	281	Dead	283	2005	2006	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PANZRV	TARGET.30.PANZRV.01A	TARGET.30.PANZRV	Male	White	Not Hispanic or Latino	72	Censored	3434	Alive	3434	2005	2015	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PANZVU	TARGET.30.PANZVU.01A	TARGET.30.PANZVU	Male	White	Not Hispanic or Latino	1713	Death	934	Dead	934	2005	2008	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Unknown	Neuroblastoma	High Risk	TMM	ALT
PAPBGH	TARGET.30.PAPBGH.01A	TARGET.30.PAPBGH	Female	Native Hawaiian or other Pacific Islander	Not Hispanic or Latino	1074	Relapse	470	Dead	723	2005	2007	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPBJE	TARGET.30.PAPBJE.01A	TARGET.30.PAPBJE	Male	White	Not Hispanic or Latino	1860	Censored	3467	Alive	3467	2005	2015	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPBZI	TARGET.30.PAPBZI.01A	TARGET.30.PAPBZI	Male	White	Not Hispanic or Latino	1710	Progression	172	Dead	430	2005	2007	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Unknown	Neuroblastoma	High Risk	TMM	Telomerase
PAPCTS	TARGET.30.PAPCTS.01A	TARGET.30.PAPCTS	Male	Black or African American	Not Hispanic or Latino	2008	Relapse	2236	Dead	2636	2005	2013	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPEFE	TARGET.30.PAPEFE.01A	TARGET.30.PAPEFE	Male	Black or African American	Not Hispanic or Latino	990	Progression	138	Dead	150	2005	2006	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPICY	TARGET.30.PAPICY.01A	TARGET.30.PAPICY	Female	White	Not Hispanic or Latino	58	Censored	205	Alive	205	2006	2006	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PAPKWN	TARGET.30.PAPKWN.01A	TARGET.30.PAPKWN	Female	White	Unknown	710	Relapse	260	Dead	465	2006	2007	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPKXS	TARGET.30.PAPKXS.01A	TARGET.30.PAPKXS	Female	White	Not Hispanic or Latino	2547	Relapse	978	Dead	2384	2006	2012	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PAPLSD	TARGET.30.PAPLSD.01A	TARGET.30.PAPLSD	Male	White	Not Hispanic or Latino	710	Relapse	583	Dead	1383	2006	2010	Stage 4	Not Amplified	Diploid (DI=1)	Unknown	Unknown	Neuroblastoma	High Risk	TMM	Telomerase
PAPTAN	TARGET.30.PAPTAN.01A	TARGET.30.PAPTAN	Male	Black or African American	Not Hispanic or Latino	1462	Censored	2054	Alive	2054	2006	2012	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Unknown	Ganglioneuroblastoma, nodular	High Risk	TMM	ALT
PAPTCR	TARGET.30.PAPTCR.01A	TARGET.30.PAPTCR	Female	White	Not Hispanic or Latino	754	Event	394	Dead	456	2006	2007	Stage 4	Unknown	Unknown	Unknown	Unknown	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PAPTDH	TARGET.30.PAPTDH.01A	TARGET.30.PAPTDH	Female	White	Not Hispanic or Latino	11	Second Malignant Neoplasm	193	Alive	2866	2006	2014	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PAPTFZ	TARGET.30.PAPTFZ.01A	TARGET.30.PAPTFZ	Male	Black or African American	Not Hispanic or Latino	564	Relapse	516	Dead	779	2006	2008	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPTLV	TARGET.30.PAPTLV.01A	TARGET.30.PAPTLV	Female	White	Not Hispanic or Latino	641	Relapse	366	Dead	575	2006	2008	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPUWY	TARGET.30.PAPUWY.01A	TARGET.30.PAPUWY	Female	White	Not Hispanic or Latino	1955	Relapse	765	Dead	1102	2006	2009	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPVFD	TARGET.30.PAPVFD.01A	TARGET.30.PAPVFD	Male	White	Not Hispanic or Latino	1961	Death	1765	Dead	1765	2006	2011	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Unknown	Neuroblastoma	High Risk	TMM	ALT
PAPVRN	TARGET.30.PAPVRN.01A	TARGET.30.PAPVRN	Male	White	Not Hispanic or Latino	2300	Censored	2889	Alive	2889	2006	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Differentiating	Ganglioneuroblastoma, nodular	High Risk	NO_TMM	NO_TMM
PAPVXS	TARGET.30.PAPVXS.01A	TARGET.30.PAPVXS	Male	Black or African American	Not Hispanic or Latino	1366	Death	224	Dead	224	2006	2007	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPZYP	TARGET.30.PAPZYP.01A	TARGET.30.PAPZYP	Female	White	Hispanic or Latino	1010	Censored	2386	Alive	2386	2007	2013	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAPZYZ	TARGET.30.PAPZYZ.01A	TARGET.30.PAPZYZ	Female	Black or African American	Not Hispanic or Latino	550	Censored	1209	Alive	1209	2007	2010	Stage 4	Amplified	Hyperdiploid (DI>1)	Unknown	Unknown	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PARACM	TARGET.30.PARACM.01A	TARGET.30.PARACM	Female	Black or African American	Not Hispanic or Latino	1442	Censored	2994	Alive	2994	2007	2015	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PARACS	TARGET.30.PARACS.01A	TARGET.30.PARACS	Male	White	Not Hispanic or Latino	1180	Censored	1328	Alive	1328	2007	2010	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PARAMT	TARGET.30.PARAMT.01A	TARGET.30.PARAMT	Male	White	Not Hispanic or Latino	885	Death	493	Dead	493	2007	2008	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PARBAJ	TARGET.30.PARBAJ.01A	TARGET.30.PARBAJ	Male	White	Not Hispanic or Latino	35	Relapse	302	Alive	2666	2007	2014	Stage 3	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PARBAJ	TARGET.30.PARBAJ.02A	TARGET.30.PARBAJ	Male	White	Not Hispanic or Latino	35	Relapse	302	Alive	2666	2007	2014	Stage 3	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PARBGP	TARGET.30.PARBGP.01A	TARGET.30.PARBGP	Female	Black or African American	Not Hispanic or Latino	3625	Relapse	1524	Dead	2039	2007	2012	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PARDCK	TARGET.30.PARDCK.01A	TARGET.30.PARDCK	Female	White	Not Hispanic or Latino	2060	Censored	2991	Alive	2991	2007	2015	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Unknown	Ganglioneuroblastoma, nodular	High Risk	TMM	ALT
PARDIW	TARGET.30.PARDIW.01A	TARGET.30.PARDIW	Male	White	Not Hispanic or Latino	2048	Censored	2829	Alive	2829	2007	2015	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PARFWB	TARGET.30.PARFWB.01A	TARGET.30.PARFWB	Male	White	Not Hispanic or Latino	1555	Relapse	1105	Dead	1836	2007	2012	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PARGKK	TARGET.30.PARGKK.01A	TARGET.30.PARGKK	Male	Black or African American	Not Hispanic or Latino	2241	Progression	1075	Dead	1321	2007	2011	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Differentiating	Neuroblastoma	High Risk	TMM	Telomerase
PARHAM	TARGET.30.PARHAM.02A	TARGET.30.PARHAM	Female	White	Not Hispanic or Latino	341	Progression	38	Dead	2466	2007	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Favorable	Unknown	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PARHAM	TARGET.30.PARHAM.01A	TARGET.30.PARHAM	Female	White	Not Hispanic or Latino	341	Progression	38	Dead	2466	2007	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Favorable	Unknown	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PARJVP	TARGET.30.PARJVP.01A	TARGET.30.PARJVP	Male	Unknown	Not Hispanic or Latino	56	Censored	2064	Alive	2064	2007	2013	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PARKGJ	TARGET.30.PARKGJ.01A	TARGET.30.PARKGJ	Male	White	Not Hispanic or Latino	1616	Relapse	841	Dead	1636	2007	2012	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PARNNC	TARGET.30.PARNNC.01A	TARGET.30.PARNNC	Female	White	Not Hispanic or Latino	41	Relapse	735	Alive	2611	2007	2014	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PARSBI	TARGET.30.PARSBI.01A	TARGET.30.PARSBI	Female	White	Not Hispanic or Latino	2390	Relapse	1377	Dead	1743	2007	2012	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PARYNK	TARGET.30.PARYNK.01A	TARGET.30.PARYNK	Female	White	Hispanic or Latino	2279	Censored	2351	Alive	2351	2008	2014	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PARZCJ	TARGET.30.PARZCJ.01A	TARGET.30.PARZCJ	Male	White	Not Hispanic or Latino	242	Censored	2435	Alive	2435	2008	2015	Stage 3	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PARZHA	TARGET.30.PARZHA.01A	TARGET.30.PARZHA	Male	Unknown	Unknown	3	Censored	2489	Alive	2489	2008	2015	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PARZIP	TARGET.30.PARZIP.01A	TARGET.30.PARZIP	Male	Unknown	Unknown	2273	Relapse	632	Alive	2511	2008	2015	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PASCFC	TARGET.30.PASCFC.01A	TARGET.30.PASCFC	Male	White	Not Hispanic or Latino	18	Censored	2522	Alive	2522	2008	2015	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PASCTR	TARGET.30.PASCTR.01A	TARGET.30.PASCTR	Male	White	Not Hispanic or Latino	60	Censored	2325	Alive	2325	2008	2014	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PASEGA	TARGET.30.PASEGA.01A	TARGET.30.PASEGA	Male	White	Not Hispanic or Latino	1091	Progression	469	Dead	809	2008	2010	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PASFGG	TARGET.30.PASFGG.01A	TARGET.30.PASFGG	Female	White	Not Hispanic or Latino	1037	Death	700	Dead	700	2008	2010	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASFIC	TARGET.30.PASFIC.01A	TARGET.30.PASFIC	Male	White	Not Hispanic or Latino	51	Censored	2152	Alive	2152	2008	2014	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PASGAP	TARGET.30.PASGAP.02A	TARGET.30.PASGAP	Male	Black or African American	Not Hispanic or Latino	1330	Progression	1285	Dead	1543	2008	2013	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PASGAP	TARGET.30.PASGAP.01A	TARGET.30.PASGAP	Male	Black or African American	Not Hispanic or Latino	1330	Progression	1285	Dead	1543	2008	2013	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PASGUT	TARGET.30.PASGUT.01A	TARGET.30.PASGUT	Male	White	Hispanic or Latino	1259	Censored	401	Alive	401	2008	2009	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	ALT
PASHFA	TARGET.30.PASHFA.01A	TARGET.30.PASHFA	Female	White	Not Hispanic or Latino	406	Progression	201	Dead	333	2008	2009	Stage 3	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASJZC	TARGET.30.PASJZC.01A	TARGET.30.PASJZC	Female	White	Not Hispanic or Latino	74	Relapse	367	Alive	2083	2009	2014	Stage 4s	Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PASMDM	TARGET.30.PASMDM.01A	TARGET.30.PASMDM	Male	White	Not Hispanic or Latino	25	Censored	1324	Alive	1324	2009	2012	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PASMJG	TARGET.30.PASMJG.01A	TARGET.30.PASMJG	Female	Not Reported	Not Hispanic or Latino	1765	Progression	1162	Dead	1544	2009	2013	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PASMNT	TARGET.30.PASMNT.01A	TARGET.30.PASMNT	Female	Native Hawaiian or other Pacific Islander	Not Hispanic or Latino	4802	Progression	233	Dead	1696	2009	2013	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PASNEF	TARGET.30.PASNEF.01A	TARGET.30.PASNEF	Female	Not Reported	Hispanic or Latino	696	Censored	2213	Alive	2213	2009	2015	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASNML	TARGET.30.PASNML.01A	TARGET.30.PASNML	Male	Not Reported	Not Hispanic or Latino	8	Censored	2185	Alive	2185	2009	2015	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PASNPG	TARGET.30.PASNPG.01A	TARGET.30.PASNPG	Female	Black or African American	Not Hispanic or Latino	318	Event	302	Alive	1918	2009	2014	Stage 3	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PASNPG	TARGET.30.PASNPG.02A	TARGET.30.PASNPG	Female	Black or African American	Not Hispanic or Latino	318	Event	302	Alive	1918	2009	2014	Stage 3	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PASNZU	TARGET.30.PASNZU.01A	TARGET.30.PASNZU	Male	Black or African American	Not Hispanic or Latino	1099	Relapse	954	Dead	1692	2009	2013	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASPBZ	TARGET.30.PASPBZ.01A	TARGET.30.PASPBZ	Male	Black or African American	Not Hispanic or Latino	62	Censored	1983	Alive	1983	2009	2014	Stage 4s	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PASPER	TARGET.30.PASPER.01A	TARGET.30.PASPER	Female	White	Hispanic or Latino	753	Progression	638	Alive	2087	2009	2014	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PASRFS	TARGET.30.PASRFS.01A	TARGET.30.PASRFS	Female	White	Not Hispanic or Latino	1328	Relapse	1675	Alive	2075	2009	2014	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PASSRN	TARGET.30.PASSRN.01A	TARGET.30.PASSRN	Male	White	Not Hispanic or Latino	5345	Censored	1947	Alive	1947	2009	2014	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASSRS	TARGET.30.PASSRS.01A	TARGET.30.PASSRS	Male	Unknown	Not Hispanic or Latino	2492	Relapse	861	Dead	1319	2009	2012	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PASSWW	TARGET.30.PASSWW.01A	TARGET.30.PASSWW	Male	White	Not Hispanic or Latino	7	Censored	1828	Alive	1828	2009	2014	Stage 4s	Not Amplified	Diploid (DI=1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PASTCN	TARGET.30.PASTCN.01A	TARGET.30.PASTCN	Male	White	Not Hispanic or Latino	1900	Relapse	870	Dead	1033	2009	2012	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PASTKC	TARGET.30.PASTKC.01A	TARGET.30.PASTKC	Male	White	Not Hispanic or Latino	3035	Censored	1952	Alive	1952	2009	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASUCB	TARGET.30.PASUCB.01A	TARGET.30.PASUCB	Male	White	Not Hispanic or Latino	1008	Censored	1976	Alive	1976	2009	2014	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASUML	TARGET.30.PASUML.01A	TARGET.30.PASUML	Male	Black or African American	Not Hispanic or Latino	4	Event	12	Dead	20	2009	2009	Stage 4s	Not Amplified	Diploid (DI=1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PASUYG	TARGET.30.PASUYG.01A	TARGET.30.PASUYG	Male	Black or African American	Not Hispanic or Latino	1418	Relapse	505	Alive	1990	2009	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASVRU	TARGET.30.PASVRU.01A	TARGET.30.PASVRU	Male	White	Hispanic or Latino	631	Event	254	Dead	440	2009	2010	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASWFB	TARGET.30.PASWFB.01A	TARGET.30.PASWFB	Female	Black or African American	Not Hispanic or Latino	727	Death	87	Dead	87	2009	2009	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASWIJ	TARGET.30.PASWIJ.01A	TARGET.30.PASWIJ	Male	White	Not Hispanic or Latino	2537	Censored	1940	Alive	1940	2009	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PASWVY	TARGET.30.PASWVY.01A	TARGET.30.PASWVY	Female	White	Not Hispanic or Latino	2477	Censored	1918	Alive	1918	2009	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	ALT
PASWYR	TARGET.30.PASWYR.01A	TARGET.30.PASWYR	Male	White	Not Hispanic or Latino	958	Censored	1893	Alive	1893	2009	2014	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASXGP	TARGET.30.PASXGP.01A	TARGET.30.PASXGP	Male	White	Not Hispanic or Latino	834	Censored	1898	Alive	1898	2009	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PASXHE	TARGET.30.PASXHE.01A	TARGET.30.PASXHE	Male	Black or African American	Not Hispanic or Latino	1438	Censored	2098	Alive	2098	2009	2015	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PASXIE	TARGET.30.PASXIE.01A	TARGET.30.PASXIE	Male	White	Not Hispanic or Latino	837	Censored	1758	Alive	1758	2009	2014	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASXRG	TARGET.30.PASXRG.01A	TARGET.30.PASXRG	Female	White	Unknown	1278	Censored	1749	Alive	1749	2009	2014	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PASXRJ	TARGET.30.PASXRJ.01A	TARGET.30.PASXRJ	Female	White	Not Hispanic or Latino	583	Progression	266	Alive	1837	2009	2014	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PASYPX	TARGET.30.PASYPX.01A	TARGET.30.PASYPX	Female	White	Hispanic or Latino	1514	Progression	296	Alive	1809	2009	2014	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PASZKE	TARGET.30.PASZKE.01A	TARGET.30.PASZKE	Male	White	Not Hispanic or Latino	31	Death	8	Dead	8	2009	2009	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Unknown	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PASZPI	TARGET.30.PASZPI.01A	TARGET.30.PASZPI	Male	White	Not Hispanic or Latino	645	Progression	453	Dead	1014	2009	2012	Stage 4	Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PATAYJ	TARGET.30.PATAYJ.01A	TARGET.30.PATAYJ	Male	White	Not Hispanic or Latino	52	Censored	1744	Alive	1744	2009	2014	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PATBMM	TARGET.30.PATBMM.01A	TARGET.30.PATBMM	Male	White	Not Hispanic or Latino	1112	Relapse	709	Alive	768	2009	2011	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PATCFL	TARGET.30.PATCFL.01A	TARGET.30.PATCFL	Male	White	Not Hispanic or Latino	1041	Censored	1754	Alive	1754	2009	2014	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PATDWN	TARGET.30.PATDWN.01A	TARGET.30.PATDWN	Male	Not Reported	Hispanic or Latino	1435	Censored	278	Alive	278	2009	2010	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PATDXC	TARGET.30.PATDXC.01A	TARGET.30.PATDXC	Male	White	Not Hispanic or Latino	1659	Event	444	Dead	916	2009	2012	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PATEPF	TARGET.30.PATEPF.01A	TARGET.30.PATEPF	Male	White	Hispanic or Latino	1434	Death	304	Dead	304	2010	2010	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Ganglioneuroblastoma, nodular	High Risk	TMM	Telomerase
PATESI	TARGET.30.PATESI.01A	TARGET.30.PATESI	Male	Black or African American	Not Hispanic or Latino	752	Relapse	622	Dead	958	2010	2012	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PATFCY	TARGET.30.PATFCY.01A	TARGET.30.PATFCY	Male	White	Not Hispanic or Latino	1040	Death	787	Dead	787	2010	2012	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PATFXV	TARGET.30.PATFXV.01A	TARGET.30.PATFXV	Female	White	Hispanic or Latino	648	Progression	236	Dead	296	2010	2010	Stage 4	Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PATGJU	TARGET.30.PATGJU.01A	TARGET.30.PATGJU	Female	White	Not Hispanic or Latino	59	Censored	1219	Alive	1219	2010	2013	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Low Risk	NO_TMM	NO_TMM
PATGLU	TARGET.30.PATGLU.01A	TARGET.30.PATGLU	Male	White	Not Hispanic or Latino	1037	Relapse	715	Dead	1330	2010	2013	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	ALT
PATHKB	TARGET.30.PATHKB.01A	TARGET.30.PATHKB	Male	White	Not Hispanic or Latino	7	Censored	1573	Alive	1573	2010	2014	Stage 4s	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PATHVK	TARGET.30.PATHVK.01A	TARGET.30.PATHVK	Female	White	Not Hispanic or Latino	2109	Progression	171	Alive	1807	2010	2015	Stage 4	Not Amplified	Hyperdiploid (DI>1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	NO_TMM	NO_TMM
PATINJ	TARGET.30.PATINJ.01A	TARGET.30.PATINJ	Male	White	Not Hispanic or Latino	1037	Relapse	736	Dead	822	2010	2012	Stage 4	Not Amplified	Diploid (DI=1)	Unfavorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	High Risk	TMM	Telomerase
PAUDDK	TARGET.30.PAUDDK.02A	TARGET.30.PAUDDK	Male	Black or African American	Not Hispanic or Latino	361	Event	344	Alive	1528	2011	2015	Stage 3	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM
PAUDDK	TARGET.30.PAUDDK.01A	TARGET.30.PAUDDK	Male	Black or African American	Not Hispanic or Latino	361	Event	344	Alive	1528	2011	2015	Stage 3	Not Amplified	Hyperdiploid (DI>1)	Favorable	Undifferentiated or Poorly Differentiated	Neuroblastoma	Intermediate Risk	NO_TMM	NO_TMM